Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:57:39.477Z.
Calculation as of: 2026-10-06T16:57:39.477Z.
Quote observation: 2026-10-06T16:55:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bddae1a009f0b40e7fb659cb125a310776fd64778f9839bff19075a224db575c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$169.76M
Free Cash Flow Yield
N/A
TTM Avg
12.80%
3Y Avg
12.80%
5Y Avg
12.80%
Market Cap
$171.14M
Free Cash Flow Yield
12.18%
TTM Avg
7.35%
3Y Avg
3.01%
5Y Avg
3.15%
Market Cap
$165.88M
Free Cash Flow Yield
11.07%
TTM Avg
9.84%
3Y Avg
5.75%
5Y Avg
5.19%
Market Cap
$172.83M
Free Cash Flow Yield
N/A
TTM Avg
0.25%
3Y Avg
0.25%
5Y Avg
0.25%
Market Cap
$173.48M
Free Cash Flow Yield
N/A
TTM Avg
6.14%
3Y Avg
6.14%
5Y Avg
6.14%
Market Cap
$175.21M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$162.75M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $169.20M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $169.76M | N/A | 12.80% | 12.80% | 12.80% |
| Organogenesis Holdings Inc. (ORGO)vs › | $171.14M | 12.18% | 7.35% | 3.01% | 3.15% |
| OptimizeRx Corp. (OPRX)vs › | $165.88M | 11.07% | 9.84% | 5.75% | 5.19% |
| Precision BioSciences, Inc. (DTIL)vs › | $172.83M | N/A | 0.25% | 0.25% | 0.25% |
| Cue Biopharma, Inc. (CUE)vs › | $172.49M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.48M | N/A | 6.14% | 6.14% | 6.14% |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.21M | N/A | N/A | N/A | N/A |
| Quanterix Corporation (QTRX)vs › | $162.75M | N/A | N/A | N/A | N/A |
| PepGen Inc. (PEPG)vs › | $161.51M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
